On the public citation graph
Antidepressants for Treating Depression Among Older Adults with Dementia: A Systematic Review and Meta-Analysis
0 signed · 40 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archpsyc.60.7.737openalex-extracted
Treating Depression in Alzheimer Disease
inferredcites →https://doi.org/10.1001/archpsyc.63.5.530openalex-extracted
Depression and Risk for Alzheimer Disease
inferredcites →https://doi.org/10.1002/(sici)1099-1166(199802)13:2<100::aid-gps738>3.0.co;2-jopenalex-extracted
A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia
inferredcites →https://doi.org/10.1002/14651858.cd003944.pub2openalex-extracted
Antidepressants for treating depression in dementia
inferredcites →https://doi.org/10.1002/alz.12764openalex-extracted
Global, regional, and national trends of dementia incidence and risk factors, 1990–2019: A Global Burden of Disease study
inferredcites →https://doi.org/10.1007/s44192-023-00057-yopenalex-extracted
Distinguishing features of depression in dementia from primary psychiatric disease
inferredcites →https://doi.org/10.1016/j.biopsych.2005.09.014openalex-extracted
Size of Treatment Effects and Their Importance to Clinical Research and Practice
inferredcites →https://doi.org/10.1016/j.jad.2010.11.033openalex-extracted
Age- and gender-specific prevalence of depression in latest-life – Systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.parkreldis.2015.04.018openalex-extracted
Antidepressive treatments for Parkinson's disease: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.pnpbp.2020.110133openalex-extracted
An alternative approach to future diagnostic standards for major depressive disorder
inferredcites →https://doi.org/10.1016/s0033-3182(97)71461-0openalex-extracted
A Double-Blind, Randomized, Fixed-Dose Trial of Fluoxetine vs. Amitriptyline in the Treatment of Major Depression Complicating Alzheimer's Disease
inferredcites →https://doi.org/10.1016/s0140-6736(17)32802-7openalex-extracted
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
inferredcites →https://doi.org/10.1017/s104161020100761xopenalex-extracted
A Double-Blind, Placebo-Controlled Study of Fluoxetine in Depressed Patients With Alzheimer’s Disease
inferredcites →https://doi.org/10.1017/s1041610220004032openalex-extracted
Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis
inferredcites →https://doi.org/10.1055/s-2007-1014339openalex-extracted
Video Rating Analysis of Effect of Maprotiline in Patients with Dementia and Depression
inferredcites →https://doi.org/10.1097/00019442-200002000-00009openalex-extracted
A Controlled Clinical Trial of Sertraline in the Treatment of Depression in Nursing Home Patients With Late-Stage Alzheimer's Disease
inferredcites →https://doi.org/10.1097/jgp.0b013e3181c796ebopenalex-extracted
Sertraline for the Treatment of Depression in Alzheimer Disease
inferredcites →https://doi.org/10.1097/jgp.0b013e3181ec8085openalex-extracted
Continuing Treatment of Depression in the Elderly: A Systematic Review and Meta-Analysis of Double-Blinded Randomized Controlled Trials With Antidepressants
inferredcites →https://doi.org/10.1111/acps.13340openalex-extracted
Determining maximal achievable effect sizes of antidepressant therapies in placebo‐controlled trials
inferredcites →https://doi.org/10.1136/bmj.n71openalex-extracted
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
inferredcites →https://doi.org/10.1159/000102570openalex-extracted
A Placebo-Controlled Double-Blind Randomized Study of Venlafaxine in the Treatment of Depression in Dementia
inferredcites →https://doi.org/10.1159/000111082openalex-extracted
Consistency of Neuropsychiatric Syndromes across Dementias: Results from the European Alzheimer Disease Consortium
inferredcites →https://doi.org/10.1176/ajp.146.1.45openalex-extracted
Double-blind trial of imipramine in Alzheimer's disease patients with and without depression
inferredcites →https://doi.org/10.1176/appi.ajp.157.10.1686openalex-extracted
Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Sertraline in the Treatment of Depression Complicating Alzheimer’s Disease: Initial Results From the Depression in Alzheimer’s Disease Study
inferredcites →https://doi.org/10.1176/jnp.8.3.270openalex-extracted
A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease
inferredcites →https://doi.org/10.1177/070674370705200407openalex-extracted
Efficacy and Safety of Antidepressants for Treatment of Depression in Alzheimer's Disease: A Metaanalysis
inferredcites →https://doi.org/10.1177/0706743716659417openalex-extracted
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
inferredcites →https://doi.org/10.1186/s12991-020-00302-6openalex-extracted
Untreated depressive symptoms significantly worsen quality of life in old age and may lead to the misdiagnosis of dementia: a cross-sectional study
inferredcites →https://doi.org/10.1192/bjp.168.2.149openalex-extracted
Moclobemide in Elderly Patients with Cognitive Decline and Depression: An International Double-blind, Placebo-controlled Trial
inferredcites →https://doi.org/10.2147/ndt.s358367openalex-extracted
Use of Clinical Global Impressions-Severity (CGI-S) to Assess Response to Antidepressant Treatment in Patients with Treatment-Resistant Depression
inferredcites →https://doi.org/10.31222/osf.io/v7gm2openalex-extracted
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
inferredcites →https://doi.org/10.3233/jad-160225openalex-extracted
The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer’s Disease Subjects
inferredcites →https://doi.org/10.3310/hta17070openalex-extracted
Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
inferredcites →https://doi.org/10.3389/fnagi.2023.1103039openalex-extracted
Comparative efficacy and safety of antidepressant therapy for the agitation of dementia: A systematic review and network meta-analysis
inferredcites →https://doi.org/10.3389/fpsyt.2021.705749openalex-extracted
Evolution and Emerging Trends in Depression Research From 2004 to 2019: A Literature Visualization Analysis
inferredcites →https://doi.org/10.4088/jcp.17r11772openalex-extracted
Meta-Analysis of the Prevalence of Major Depressive Disorder Among Older Adults With Dementia
inferredcites →https://doi.org/10.4103/0972-2327.74248openalex-extracted
The complex relationship between depression and dementia
inferredcites →https://doi.org/10.5414/cpp46072openalex-extracted
STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation
inferredcites →https://doi.org/10.9758/cpn.2022.20.2.311openalex-extracted
Vortioxetine Treatment for Depression in Alzheimer’s Disease: A Randomized, Double-blind, Placebo-controlled Study
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.